Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related BSX
Boston Scientific Fortifies Pain Therapy Arm With FDA Nod
No Fundamental Reason For Boston Scientific Shares' Underperformance, RBC Upgrades Stock
Boston Scientific (BSX) Investor Update (North American Neuromodulation Society) - Slideshow (Seeking Alpha)
Related DELL
Smart Move: VMware Now Looking To Partner, Rather Than Compete, With The Public Cloud
An Air Tesla? JetBlue-, Boeing-Backed Startup Zunum Aero Plans Cheap Electric Flights

Analysts at JMP Securities upgraded Boston Scientific (NYSE: BSX) from “market perform” to “outperform.” Boston Scientific's shares closed at $5.54 on Friday. Boston Scientific's trailing-twelve-month revenue is $7.56 billion.

Analysts at Goldman Sachs upgraded Dell (NASDAQ: DELL) from “sell” to “buy.” Dell's stock closed at $9.64 on Friday. Dell's PEG ratio is 1.00.

Analysts at Deutsche Bank upgraded International Game Technology (NYSE: IGT) from “hold” to “buy.” International Game's shares closed at $13.87 on Friday. International Game's trailing-twelve-month operating margin is 25.06%.

Analysts at Piper Jaffray upgraded Agrium (NYSE: AGU) from “neutral” to “overweight.” Agrium's shares closed at $102.02 on Friday. Agrium had $1.86 billion in total cash for the latest quarter.

Latest Ratings for BSX

DateFirmActionFromTo
Jan 2018RBC CapitalUpgradesOutperformTop Pick
Jan 2018Evercore ISI GroupInitiates Coverage OnIn-Line
Dec 2017NeedhamUpgradesBuyStrong Buy

View More Analyst Ratings for BSX
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (AGU + BSX)

View Comments and Join the Discussion!